FDA Inspection 1326702 — Novo Nordisk Pharmaceutical Industries, LP
The FDA completed an inspection of Novo Nordisk Pharmaceutical Industries, LP on Jun 30, 2026 in Petersburg, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 30, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Petersburg, VA (United States)